4//SEC Filing
Carson Michael J. 4
Accession 0001104659-24-115837
CIK 0001875558other
Filed
Nov 7, 7:00 PM ET
Accepted
Nov 8, 3:59 PM ET
Size
8.8 KB
Accession
0001104659-24-115837
Insider Transaction Report
Form 4
Carson Michael J.
Vice President, Finance
Transactions
- Award
Common Stock
2024-01-04+34,567→ 90,673 total - Award
Common Stock
2023-01-03+28,806→ 56,106 total - Sale
Common Stock
2024-11-07$8.16/sh−2,755$22,478→ 87,918 total
Footnotes (4)
- [F1]The 28,806 shares of restricted Common Stock will vest in equal annual installments over three years beginning on the first anniversary of the grant date subject to Mr. Carson's continued service on such dates.
- [F2]Includes shares of restricted common stock, which vest over various time periods.
- [F3]The 34,567 shares of restricted Common Stock will vest in equal annual installments over three years beginning on the first anniversary of the grant date subject to Mr. Carson's continued service on such dates.
- [F4]In connection with the vesting of 9,100 shares, 2,755 shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Carson's tax withholding obligations. Mr. Carson had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock.
Documents
Issuer
Nuvectis Pharma, Inc.
CIK 0001875558
Entity typeother
Related Parties
1- filerCIK 0001896079
Filing Metadata
- Form type
- 4
- Filed
- Nov 7, 7:00 PM ET
- Accepted
- Nov 8, 3:59 PM ET
- Size
- 8.8 KB